Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects-Reference-Cited by-同舟云学术

Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects

Published:2020-12-01 Issue:12 Volume:77 Page:1246
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Anderson Kayla N.¹,Lind Jennifer N.²³,Simeone Regina M.¹,Bobo William V.⁴,Mitchell Allen A.⁵,Riehle-Colarusso Tiffany¹,Polen Kara N.¹,Reefhuis Jennita¹

Affiliation:

1. Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia

2. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

3. United States Public Health Service, Atlanta, Georgia

4. Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida

5. Slone Epidemiology Center at Boston University, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2769190/jamapsychiatry_anderson_2020_oi_200049_1606923685.3513.pdf

Reference67 articles.

1. Antidepressant prescription claims among reproductive-aged women with private employer-sponsored insurance—United States 2008–2013.;Dawson;MMWR Morb Mortal Wkly Rep,2016

2. Antidepressant use among persons aged 12 and over: United States, 2011–2014.;Pratt;NCHS Data Brief,2017